These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8610445

  • 1. Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter.
    Swaminathan S.
    Virology; 1996 Mar 15; 217(2):532-41. PubMed ID: 8610445
    [Abstract] [Full Text] [Related]

  • 2. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T, Sjöblom A, Masucci MG, Rymo L.
    Virology; 1993 Apr 15; 193(2):774-85. PubMed ID: 8384755
    [Abstract] [Full Text] [Related]

  • 3. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K.
    J Med Virol; 2003 Jul 15; 70(3):410-9. PubMed ID: 12767005
    [Abstract] [Full Text] [Related]

  • 4. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB.
    J Virol; 1992 Dec 15; 66(12):7461-8. PubMed ID: 1331531
    [Abstract] [Full Text] [Related]

  • 5. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
    Hu LF, Chen F, Altiok E, Winberg G, Klein G, Ernberg I.
    Gan To Kagaku Ryoho; 2000 May 15; 27 Suppl 2():248-60. PubMed ID: 10895161
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ.
    Kelleher CA, Paterson RK, Dreyfus DH, Streib JE, Xu JW, Takase K, Jones JF, Gelfand EW.
    Virology; 1995 Apr 20; 208(2):685-95. PubMed ID: 7747440
    [Abstract] [Full Text] [Related]

  • 7. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, Bell AI.
    J Virol; 2006 Nov 20; 80(21):10700-11. PubMed ID: 16920819
    [Abstract] [Full Text] [Related]

  • 8. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Puglielli MT, Woisetschlaeger M, Speck SH.
    J Virol; 1996 Sep 20; 70(9):5758-68. PubMed ID: 8709191
    [Abstract] [Full Text] [Related]

  • 9. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun 20; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
    McClain K, Estrov Z, Raju U, Kelley PK, Aggarwal BB.
    Methods; 1997 Jan 20; 11(1):83-7. PubMed ID: 8990093
    [Abstract] [Full Text] [Related]

  • 11. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 20; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 12. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R, Tong X, Grossman S, Johannsen E, Mosialos G, Kieff E.
    Virology; 1994 Nov 01; 204(2):634-41. PubMed ID: 7941331
    [Abstract] [Full Text] [Related]

  • 13. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia.
    Webster-Cyriaque J, Raab-Traub N.
    Virology; 1998 Aug 15; 248(1):53-65. PubMed ID: 9705255
    [Abstract] [Full Text] [Related]

  • 14. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J, Pai S, Cotter M, Robertson ES.
    Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337
    [Abstract] [Full Text] [Related]

  • 15. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C, Bernhard D, Schaadt E, Adler B, Ausserlechner MJ, Mitterer M, Huemer HP.
    Haematologica; 2003 Dec 15; 88(12):1324-35. PubMed ID: 14687985
    [Abstract] [Full Text] [Related]

  • 16. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ, Feederle R, Behrends U, Mautner J.
    Semin Cancer Biol; 2008 Dec 15; 18(6):409-15. PubMed ID: 18938248
    [Abstract] [Full Text] [Related]

  • 17. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES, Tomkinson B, Kieff E.
    J Virol; 1994 Mar 15; 68(3):1449-58. PubMed ID: 8107208
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L, Trivedi P, de Grazia U, Calogero A, D'Onofrio M, Yang W, Frati L, Faggioni A, Rymo L, Ragona G.
    J Med Virol; 1998 Jul 15; 55(3):219-26. PubMed ID: 9624610
    [Abstract] [Full Text] [Related]

  • 19. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.
    Rooney CM, Brimmell M, Buschle M, Allan G, Farrell PJ, Kolman JL.
    J Virol; 1992 Jan 15; 66(1):496-504. PubMed ID: 1309259
    [Abstract] [Full Text] [Related]

  • 20. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB, Montalvo EA, McClain KL, Ench Y, Heard P, Christy BA, Dewalt-Hagan PJ, Moyer MP.
    J Med Virol; 1999 Jan 15; 57(1):36-46. PubMed ID: 9890420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.